The Journal of Pediatrics
Volume 138, Issue 3 , Pages 361-365 , March 2001

Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants

Received 20 March 2000 ,Revised 29 June 2000 ,Accepted 30 August 2000.

References 

  1. Mrukowicz J, Krobicka B, Duplaga M, Kowalska-Duplaga K, Domanski J, Szajewska H, et al.  Epidemiology and impact of rotavirus diarrhoea in Poland. Acta Paediatr Suppl. 1999;426:53–60
  2. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis. 1990;162:598–604
  3. Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol. 1990;131:711–718
  4. Ponce MF, Rial MJ, Alarcon N, Szefner M, Aguilar MD. Use of a prospectively measured incidence rate of nosocomial diarrhea in an infant/toddler ward as a meaningful quality assessment tool. Clin Perform Qual Health Care. 1995;3:128–131
  5. Craven D, Brick D, Morrisey A, O’Riordan MA, Petran V, Schreiber JR. Low yield of bacterial stool culture in children with nosocomial diarrhea. Pediatr Infect Dis J. 1998;17:1040–1044
  6. Meropol SB, Luberti AA, De Jong AR. Yield from stool testing of pediatric inpatients. Arch Pediatr Adolesc Med. 1997;151:142–145
  7. Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R. Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol. 1997;35:1427–1432
  8. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046–1049
  9. Oberhelman RA, Gilman R, Sheen P, Taylor DN, Black RE, Cabrera L, et al.  A placebo-controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children. J Pediatr. 1999;134:15–20
  10. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrhoeal preventive in travelers. J Travel Med. 1997;1:41–43
  11. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, et al.  Prevention of traveler’s diarrhoea by Lactobacillus GG. Ann Med. 1990;22:53–56
  12. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564–568
  13. Arvola T, Laiho K, Torkkeli S, Mykkanen , Salminen S, Maunula L, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64
  14. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991;88:90–97
  15. Isolauri E, Kaila M, Mykkanen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci. 1994;39:2595–2600
  16. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child. 1995;72:51–53
  17. Shornikova A-V, Isolauri E, Burnakova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr. 1997;86:460–465
  18. Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997;25:516–519
  19. Guandalini S, Pensabene L, Abu Zikri M, Dias JA, Casali LG, Hoekstra H, et al.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European study. J Pediatr Gastroenterol Nutr. 2000;30:54–60
  20. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995;21:224–226
  21. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol. 2000;95(Suppl):S11–S13
  22. Davidson GP, Daniels E, Nunan H, Moore AG, Whyte PBD, Franklin K, et al.  Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet. 1989;2:709–712
  23. Caul EO. Small round structured viruses: airborne transmission and hospital control. Lancet. 1994;343:1240–1242
  24. Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol. 1990;131:711–718
  25. Bennet R, Hedlund KO, Ehrnst A, Eriksson M. Nosocomial gastroenteritis in two infant wards over 26 months. Acta Paediatr. 1995;84:667–670
  26. Jamieson FB, Wang EE, Bain C, Good J, Duckmanton L, Petric M. Human torovirus: a new nosocomial gastrointestinal pathogen. J Infect Dis. 1998;178:1263–1269
  27. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gaultieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci. 1992;37:121–128
  28. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother. 1987;31:1231–1233
  29. Wilson KH, Perini I. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun. 1988;56:2610–2614
  30. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 1994;35:483–489
  31. Davidson JN, Hirsch DC. Bacterial competition as a means of preventing diarrhoea in pigs. Infect Immun. 1976;13:1773–1774
  32. Rigothier MC, Maccanio J, Gayral P. Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res. 1994;80:10–15
  33. Pothoulakis C, Kelly CP, Joshi MA, Gao N, O’Keane CJ, Castagliuolo I, et al.  Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology. 1993;104:1108–1115
  34. Czrucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’,5’-cyclic monophosphate induction in intestinal cells. Gastroenterology. 1994;106:65–72
  35. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res. 1992;32:141–144
  36. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;20:333–339
  37. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol. 1999;276:G941–G950
  38. Reuman PD, Duckworth DH, Smith KL, Bagan R, Buccarelli RL, Ayoub EM. Lack of effect of Lactobacillus GG on gastrointestinal bacterial colonisation in premature infants. Pediatr Infect Dis J. 1986;5:663–668
  39. Millar MR, Bacon C, Smith SL, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child. 1993;69:483–487

☆ Supported in part by a grant from the Medical University of Warsaw (H.S.).

☆☆ Reprint requests: Hanna Szajewska, MD, Department of Pediatric Gastroenterology and Nutrition, The Medical University of Warsaw, 01-184 Warsaw, 1 Dzialdowska St, Poland.

PII: S0022-3476(01)35704-9

doi: 10.1067/mpd.2001.111321

The Journal of Pediatrics
Volume 138, Issue 3 , Pages 361-365 , March 2001

Article Tools